Neovascularization

Dr. Moshiri’s commitment to academic medicine is founded on his scientific interest in retinal genetics and retinal stem cell biology, and he pursues an active laboratory research program. His research background is in the embryonic development of the retina. Under the supervision of Professor Thomas A. Reh at the University of Washington in Seattle, Dr. Moshiri earned a Ph.D. in Neurobiology studying the genetic control of retinal stem cells during eye development. He applied these studies from the embryonic retina to replace retinal cells after injury in adult animals.

Dr. Sheibani is a Professor in the Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health. He is interested in mechanisms that keep angiogenesis in check and alterations under pathological conditions, such as ischemia or diabetes, that result in ocular neovascularization.